×
About 568 results

ALLMedicine™ Megaloblastic Anemia Center

Research & Reviews  261 results

Sub-internal limiting membrane haemorrhage following pancytopenia in megaloblastic anemia.
https://doi.org/10.1080/08164622.2021.1878842
Clinical & Experimental Optometry; Sharma A, Upadhyaya A et. al.

Mar 10th, 2021 - Sub-internal limiting membrane haemorrhage following pancytopenia in megaloblastic anemia.|2021|Sharma A,Upadhyaya A,Madan S,Singh P,Beri S,|

The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921063
The AAPS Journal; Enogieru OJ, Koleske ML et. al.

Mar 2nd, 2021 - A rare cause of megaloblastic anemia (MA) is thiamine-responsive megaloblastic anemia (TRMA), a genetic disorder caused by mutations in SLC19A2 (encoding THTR1), a thiamine transporter. The study objectives were to (1) functionally characterize se...

Clinical and molecular characteristics of imerslund-gräsbeck syndrome: First report of ...
https://doi.org/10.1111/ijlh.13473
International Journal of Laboratory Hematology; Elshinawy M, Gao HH et. al.

Jan 25th, 2021 - Imerslund-Gräsbeck syndrome (IGS) is a rare autosomal-recessive disorder characterized by selective vitamin B12 malabsorption, megaloblastic anemia, and proteinuria. The precise incidence of this disorder is unknown in the Middle East and Arab cou...

Thiamine-Responsive Megaloblastic Anemia-Related Diabetes: Long-Term Clinical Outcomes ...
https://doi.org/10.1016/j.jcjd.2020.11.006
Canadian Journal of Diabetes; Warncke K, Prinz N et. al.

Jan 3rd, 2021 - To describe clinical presentation and long-term outcomes in a large cohort of children diagnosed with thiamine-responsive megaloblastic anemia (TRMA)-related diabetes. Data from the Diabetes Patienten Verlaufsdokumentation (DPV) and Better control...

A case of megaloblastic anemia simulating a cold autoimmune hemolytic anemia.
https://www.ncbi.nlm.nih.gov/pubmed/33112632
Immunohematology De La Puerta R, Carpio N et. al.

Oct 28th, 2020 - We report a case of pernicious anemia in which the first diagnosis suspicion was cold autoimmune hemolytic anemia (cAIHA) due to the presence of cold autoantibodies. A 47-year-old woman with a medical history of autoimmune thyroid disease came to ...

see more →

Guidelines  1 results

Folic Acid: StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK554487/
Merrell BJ, McMurry JP.

Folic acid has FDA-approval for the treatment of megaloblastic and macrocytic anemias due to folic deficiency. Folic acid is a water-soluble vitamin used in the management and treatment of megaloblastic anemia.

see more →

Drugs  17 results see all →

Clinicaltrials.gov  285 results

Sub-internal limiting membrane haemorrhage following pancytopenia in megaloblastic anemia.
https://doi.org/10.1080/08164622.2021.1878842
Clinical & Experimental Optometry; Sharma A, Upadhyaya A et. al.

Mar 10th, 2021 - Sub-internal limiting membrane haemorrhage following pancytopenia in megaloblastic anemia.|2021|Sharma A,Upadhyaya A,Madan S,Singh P,Beri S,|

The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921063
The AAPS Journal; Enogieru OJ, Koleske ML et. al.

Mar 2nd, 2021 - A rare cause of megaloblastic anemia (MA) is thiamine-responsive megaloblastic anemia (TRMA), a genetic disorder caused by mutations in SLC19A2 (encoding THTR1), a thiamine transporter. The study objectives were to (1) functionally characterize se...

Clinical and molecular characteristics of imerslund-gräsbeck syndrome: First report of ...
https://doi.org/10.1111/ijlh.13473
International Journal of Laboratory Hematology; Elshinawy M, Gao HH et. al.

Jan 25th, 2021 - Imerslund-Gräsbeck syndrome (IGS) is a rare autosomal-recessive disorder characterized by selective vitamin B12 malabsorption, megaloblastic anemia, and proteinuria. The precise incidence of this disorder is unknown in the Middle East and Arab cou...

Khapzory - levoleucovorin injection, powder, lyophilized, for solution-Spectrum Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=188815dd-9d1c-4e0f-934e-972dce0d4599

Jan 18th, 2021 - KHAPZORY is indicated for: rescue after high-dose methotrexate therapy in patients with osteosarcoma. diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination. the treatment of patients wit...

Levoleucovorin - levoleucovorin injection, powder, lyophilized, for solution-Amneal Pharmaceuticals LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23efb660-8c30-4d9c-99e7-31d982884e76

Jan 4th, 2021 - Levoleucovorin for injection is indicated for: rescue after high-dose methotrexate therapy in adult and pediatric patients with osteosarcoma. diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate el...

see more →

News  3 results

November 2016 Quiz 2
https://www.mdedge.com/gihepnews/article/117470/november-2016-quiz-2

Nov 7th, 2016 - Q2: Answer: B This is likely a tapeworm infection with Diphyllobothrium latum, and most tapeworm infections are treated with praziquantel. D.

Addisonian Pigmentation and Vitamin B12 Deficiency: A Case Series and Review of the Literature
https://www.mdedge.com/dermatology/article/76685/pigmentation-disorders/addisonian-pigmentation-and-vitamin-b12-deficiency
Madhukara Jithendriya, Dvd, DNB, Sendhil Kumaran, MD, DNB et. al.

Jul 29th, 2013 - Skin changes associated with vitamin B12 deficiency are common. In most cases, patients present primarily with systemic involvement (eg, megaloblastic anemia and/or neurologic effects), and additional cutaneous changes related to the diagnosis are.

Folic Acid: StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK554487/
Merrell BJ, McMurry JP.

Folic acid has FDA-approval for the treatment of megaloblastic and macrocytic anemias due to folic deficiency. Folic acid is a water-soluble vitamin used in the management and treatment of megaloblastic anemia.

see more →

Patient Education  1 results see all →